127 related articles for article (PubMed ID: 36279596)
1. Intolerance to quinidine in a n-of-1 trial for KCNT1 associated epilepsy of infancy with migrating focal seizures.
Hughes E; Oates S; Pal DK
Seizure; 2022 Dec; 103():46-50. PubMed ID: 36279596
[TBL] [Abstract][Full Text] [Related]
2. Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.
Dilena R; DiFrancesco JC; Soldovieri MV; Giacobbe A; Ambrosino P; Mosca I; Galli MA; Guez S; Fumagalli M; Miceli F; Cattaneo D; Darra F; Gennaro E; Zara F; Striano P; Castellotti B; Gellera C; Varesio C; Veggiotti P; Taglialatela M
Neurotherapeutics; 2018 Oct; 15(4):1112-1126. PubMed ID: 30112700
[TBL] [Abstract][Full Text] [Related]
3. KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report.
Takase C; Shirai K; Matsumura Y; Watanabe T; Watanabe A; Hirasawa-Inoue A; Mizuguchi T; Matsumoto N; Sugai K; Hayashi M
Brain Dev; 2020 Sep; 42(8):607-611. PubMed ID: 32505479
[TBL] [Abstract][Full Text] [Related]
4. KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases.
Borlot F; Abushama A; Morrison-Levy N; Jain P; Puthenveettil Vinayan K; Abukhalid M; Aldhalaan HM; Almuzaini HS; Gulati S; Hershkovitz T; Konanki R; Lingappa L; Luat AF; Shafi S; Tabarki B; Thomas M; Yoganathan S; Alfadhel M; Arya R; Donner EJ; Ehaideb SN; Gowda VK; Jain V; Madaan P; Myers KA; Otsubo H; Panda P; Sahu JK; Sampaio LPB; Sharma S; Simard-Tremblay E; Zak M; Whitney R
Epilepsia; 2020 Apr; 61(4):679-692. PubMed ID: 32167590
[TBL] [Abstract][Full Text] [Related]
5. Two Patients With KCNT1-Related Epilepsy Responding to Phenobarbital and Potassium Bromide.
Datta AN; Michoulas A; Guella I; ; Demos M
J Child Neurol; 2019 Oct; 34(12):728-734. PubMed ID: 31208268
[No Abstract] [Full Text] [Related]
6. Clinical and molecular characterization of
McTague A; Nair U; Malhotra S; Meyer E; Trump N; Gazina EV; Papandreou A; Ngoh A; Ackermann S; Ambegaonkar G; Appleton R; Desurkar A; Eltze C; Kneen R; Kumar AV; Lascelles K; Montgomery T; Ramesh V; Samanta R; Scott RH; Tan J; Whitehouse W; Poduri A; Scheffer IE; Chong WKK; Cross JH; Topf M; Petrou S; Kurian MA
Neurology; 2018 Jan; 90(1):e55-e66. PubMed ID: 29196579
[TBL] [Abstract][Full Text] [Related]
7. Quinidine therapy and therapeutic drug monitoring in four patients with KCNT1 mutations.
Yoshitomi S; Takahashi Y; Yamaguchi T; Oboshi T; Horino A; Ikeda H; Imai K; Okanishi T; Nakashima M; Saitsu H; Matsumoto N; Yoshimoto J; Fujita T; Ishii A; Hirose S; Inoue Y
Epileptic Disord; 2019 Feb; 21(1):48-54. PubMed ID: 30782581
[TBL] [Abstract][Full Text] [Related]
8. Precision therapy for epilepsy due to
Mullen SA; Carney PW; Roten A; Ching M; Lightfoot PA; Churilov L; Nair U; Li M; Berkovic SF; Petrou S; Scheffer IE
Neurology; 2018 Jan; 90(1):e67-e72. PubMed ID: 29196578
[TBL] [Abstract][Full Text] [Related]
9. A quinidine non responsive novel KCNT1 mutation in an Indian infant with epilepsy of infancy with migrating focal seizures.
Madaan P; Jauhari P; Gupta A; Chakrabarty B; Gulati S
Brain Dev; 2018 Mar; 40(3):229-232. PubMed ID: 29037447
[TBL] [Abstract][Full Text] [Related]
10. Lack of response to quinidine in KCNT1-related neonatal epilepsy.
Numis AL; Nair U; Datta AN; Sands TT; Oldham MS; Patel A; Li M; Gazina E; Petrou S; Cilio MR
Epilepsia; 2018 Oct; 59(10):1889-1898. PubMed ID: 30182418
[TBL] [Abstract][Full Text] [Related]
11. KCNT1 epilepsy with migrating focal seizures shows a temporal sequence with poor outcome, high mortality and SUDEP.
Kuchenbuch M; Barcia G; Chemaly N; Carme E; Roubertie A; Gibaud M; Van Bogaert P; de Saint Martin A; Hirsch E; Dubois F; Sarret C; Nguyen The Tich S; Laroche C; des Portes V; Billette de Villemeur T; Barthez MA; Auvin S; Bahi-Buisson N; Desguerre I; Kaminska A; Benquet P; Nabbout R
Brain; 2019 Oct; 142(10):2996-3008. PubMed ID: 31532509
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies.
M Qunies A; A Emmitte K
Pharm Pat Anal; 2022 Mar; 11(2):45-56. PubMed ID: 35369761
[TBL] [Abstract][Full Text] [Related]
13. KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum.
Bonardi CM; Heyne HO; Fiannacca M; Fitzgerald MP; Gardella E; Gunning B; Olofsson K; Lesca G; Verbeek N; Stamberger H; Striano P; Zara F; Mancardi MM; Nava C; Syrbe S; Buono S; Baulac S; Coppola A; Weckhuysen S; Schoonjans AS; Ceulemans B; Sarret C; Baumgartner T; Muhle H; Portes VD; Toulouse J; Nougues MC; Rossi M; Demarquay G; Ville D; Hirsch E; Maurey H; Willems M; de Bellescize J; Altuzarra CD; Villeneuve N; Bartolomei F; Picard F; Hornemann F; Koolen DA; Kroes HY; Reale C; Fenger CD; Tan WH; Dibbens L; Bearden DR; Møller RS; Rubboli G
Brain; 2021 Dec; 144(12):3635-3650. PubMed ID: 34114611
[TBL] [Abstract][Full Text] [Related]
14. Treatment Responsiveness in KCNT1-Related Epilepsy.
Fitzgerald MP; Fiannacca M; Smith DM; Gertler TS; Gunning B; Syrbe S; Verbeek N; Stamberger H; Weckhuysen S; Ceulemans B; Schoonjans AS; Rossi M; Demarquay G; Lesca G; Olofsson K; Koolen DA; Hornemann F; Baulac S; Rubboli G; Minks KQ; Lee B; Helbig I; Dlugos D; Møller RS; Bearden D
Neurotherapeutics; 2019 Jul; 16(3):848-857. PubMed ID: 31054119
[TBL] [Abstract][Full Text] [Related]
15. New use for an old drug: quinidine in KCNT1-related epilepsy therapy.
Liu R; Sun L; Wang Y; Wang Q; Wu J
Neurol Sci; 2023 Apr; 44(4):1201-1206. PubMed ID: 36437393
[TBL] [Abstract][Full Text] [Related]
16. Response to cannabidiol in epilepsy of infancy with migrating focal seizures associated with KCNT1 mutations: An open-label, prospective, interventional study.
Poisson K; Wong M; Lee C; Cilio MR
Eur J Paediatr Neurol; 2020 Mar; 25():77-81. PubMed ID: 31926846
[TBL] [Abstract][Full Text] [Related]
17. Does age affect response to quinidine in patients with KCNT1 mutations? Report of three new cases and review of the literature.
Abdelnour E; Gallentine W; McDonald M; Sachdev M; Jiang YH; Mikati MA
Seizure; 2018 Feb; 55():1-3. PubMed ID: 29291456
[TBL] [Abstract][Full Text] [Related]
18. A challenging case of epilepsy in infancy with migrating focal seizures due to a de novo KCNT1 missense variant (c.1438G>A, p.Asp480Asn).
León-Ruiz M; Alonso-Singer P; Merino-Andreu M; Castañeda-Cabrero C
Seizure; 2024 Apr; 117():202-205. PubMed ID: 38461786
[No Abstract] [Full Text] [Related]
19. Precision therapy with quinidine of KCNT1-related epileptic disorders: A systematic review.
Xu D; Chen S; Yang J; Wang X; Fang Z; Li M
Br J Clin Pharmacol; 2022 Dec; 88(12):5096-5112. PubMed ID: 35940594
[TBL] [Abstract][Full Text] [Related]
20. In silico model reveals the key role of GABA in KCNT1-epilepsy in infancy with migrating focal seizures.
Kuchenbuch M; Nabbout R; Yochum M; Sauleau P; Modolo J; Wendling F; Benquet P
Epilepsia; 2021 Mar; 62(3):683-697. PubMed ID: 33617692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
